Last visit was: 27 Apr 2024, 02:33 It is currently 27 Apr 2024, 02:33

Close
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Close
Request Expert Reply
Confirm Cancel
SORT BY:
Date
Tags:
Show Tags
Hide Tags
Math Expert
Joined: 02 Sep 2009
Posts: 92952
Own Kudos [?]: 619318 [4]
Given Kudos: 81611
Send PM
Math Expert
Joined: 02 Sep 2009
Posts: 92952
Own Kudos [?]: 619318 [0]
Given Kudos: 81611
Send PM
Fuqua Moderator
Joined: 21 Jul 2021
Posts: 267
Own Kudos [?]: 173 [0]
Given Kudos: 56
GMAT 1: 710 Q50 V36
GMAT 2: 710 Q50 V36
Send PM
LBS Moderator
Joined: 25 Apr 2020
Posts: 164
Own Kudos [?]: 128 [1]
Given Kudos: 99
Location: India
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
Bunuel wrote:
The year-end sales report from a veterinary vaccine company states the following:

    A regulation significantly curbing the use of mink furs to manufacture garments was passed during the middle of this year. However, compared to last year, there was no change in the revenues from the sales of the vaccine Minkvac that is mandatory to be administered to all the minks that are used to manufacture garments.

Because of the above report, the managers of the vaccine company did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year.

Which of the following options, if true, indicates most strongly that the projection made by the managers for the next year mentioned in the passage would most likely not be met?


A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.


 


This question was provided by GMAT Club
for the GMAT Club World Cup Competition

Compete, Get Better, Win prizes and more

 



Thank you sayantanc2k for the question!!!


Any option which suggest revenue came before mid of last year, can simply fail the manager's prediction.

A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year: Not relevant. Reject

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned: Not relevant. Reject

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be: Not relevant. Reject

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter: Correct

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected: Not relevant. Reject

D is the correct option
Manager
Manager
Joined: 09 Jun 2021
Posts: 83
Own Kudos [?]: 60 [1]
Given Kudos: 24
Location: India
GMAT 1: 690 Q49 V35
GMAT 2: 760 Q50 V42
GPA: 3.2
WE:Information Technology (Computer Software)
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
Weaken question

Correct answer : Choice D

A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year. - Wrong : Does not weaken the argument. Has nothing to do with MinkVak and its sales

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.- Wrong : Does not weaken the argument. Has nothing to do with MinkVak and its sales

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.- Wrong : Does not weaken the argument. Effectiveness is not key point in question.

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.- Correct : Ahhhh, this makes sense. Even though the sales of the vaccine was unchanged this year in spite of the regulation which happened mid-year, The reason was , all the sales were attributed to the first half the year. This wont be the case next year

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected. - Wrong : not relevant .
GMAT Club Legend
GMAT Club Legend
Joined: 18 Aug 2017
Status:You learn more from failure than from success.
Posts: 8020
Own Kudos [?]: 4099 [1]
Given Kudos: 242
Location: India
Concentration: Sustainability, Marketing
GMAT Focus 1:
545 Q79 V79 DI73
GPA: 4
WE:Marketing (Energy and Utilities)
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
A regulation significantly curbing the use of mink furs to manufacture garments was passed during the middle of this year. However, compared to last year, there was no change in the revenues from the sales of the vaccine

Conclusion : Minkvac that is mandatory to be administered to all the minks that are used to manufacture garments

the managers of the vaccine company did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year.

A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year. not relevant

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned. this is a strengthener


C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be. not relevant

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter correct option also the fact that regulation has curbed the sale of mink so impact can also come in next year.

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.


not relevant


OPTION D is correct


Bunuel wrote:
The year-end sales report from a veterinary vaccine company states the following:

    A regulation significantly curbing the use of mink furs to manufacture garments was passed during the middle of this year. However, compared to last year, there was no change in the revenues from the sales of the vaccine Minkvac that is mandatory to be administered to all the minks that are used to manufacture garments.

Because of the above report, the managers of the vaccine company did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year.

Which of the following options, if true, indicates most strongly that the projection made by the managers for the next year mentioned in the passage would most likely not be met?


A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.


 


This question was provided by GMAT Club
for the GMAT Club World Cup Competition

Compete, Get Better, Win prizes and more

 



Thank you sayantanc2k for the question!!!
Manager
Manager
Joined: 23 Aug 2021
Posts: 216
Own Kudos [?]: 145 [1]
Given Kudos: 75
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
Answer is D
A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.
Irrelevant
B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.
Irrelevant
C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.
Irrelevant
D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.
Yes, the regulation passed in the middle of the year, so this regulation do not have affect on the sales of this year but
will definitely affect the sales of next year.

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected. what?
Manager
Manager
Joined: 01 May 2019
Posts: 78
Own Kudos [?]: 42 [0]
Given Kudos: 33
Location: India
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
IMO D

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.-- Correct
Director
Director
Joined: 06 Dec 2021
Posts: 641
Own Kudos [?]: 519 [1]
Given Kudos: 737
Location: India
Concentration: Technology, International Business
GPA: 4
WE:Human Resources (Telecommunications)
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
Which of the following options, if true, indicates most strongly that the projection made by the managers for the next year mentioned in the passage would most likely not be met?

A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year. out of scope

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned. out of scope

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be. out of scope

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter. Correct as it weakens the projection made by manager

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected. incorrect

AnswerD
GMAT Club Legend
GMAT Club Legend
Joined: 03 Jun 2019
Posts: 5344
Own Kudos [?]: 3969 [1]
Given Kudos: 160
Location: India
GMAT 1: 690 Q50 V34
WE:Engineering (Transportation)
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
The year-end sales report from a veterinary vaccine company states the following:

    A regulation significantly curbing the use of mink furs to manufacture garments was passed during the middle of this year. However, compared to last year, there was no change in the revenues from the sales of the vaccine Minkvac that is mandatory to be administered to all the minks that are used to manufacture garments.

Because of the above report, the managers of the vaccine company did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year.

Which of the following options, if true, indicates most strongly that the projection made by the managers for the next year mentioned in the passage would most likely not be met?


Quote:
A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.

We not concerned with any other vaccine other than Minkvac.
Incorrect

Quote:
B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.

We not concerned with any other vaccine other than Minkvac.
Incorrect

Quote:
C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.

Unless the results of latest clinical trials for Minkvac are published and affects sales, the statement does not affect sales of Minkvac vaccine.
Incorrect

Quote:
D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.

Since the regulations were introduced in the middle of the year (after second quarter) and almost all vaccines are sold in the first quarter. Therefore, sales of Minkvac vaccine was not affected this year. But the same may not hold true for next year and projections made by managers most likely may not be met.
Correct

Quote:
E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.

This statement actually supports managers prediction that despite high-performing sales managers responsible for Minkvac leaving sales projections will be met.
Incorrect

IMO D
Manager
Manager
Joined: 30 May 2017
Posts: 247
Own Kudos [?]: 749 [0]
Given Kudos: 2265
Location: United States
Schools: HBS '22
GMAT 1: 690 Q50 V33
GRE 1: Q168 V164
GPA: 3.57
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
IMO, Option C is the answer.
Manager
Manager
Joined: 27 Jan 2017
Posts: 106
Own Kudos [?]: 107 [1]
Given Kudos: 483
Location: India
GMAT 1: 640 Q46 V34
GMAT 2: 650 Q46 V34
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.Out of Scope.OUT

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.OUT OF SCOPE.out

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.Not at all weakening the conclusion.OUT

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.CORRECT.

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.OUT OF SCOPE .OUT

OA:D
Manager
Manager
Joined: 17 Sep 2020
Posts: 101
Own Kudos [?]: 129 [1]
Given Kudos: 222
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
Bunuel wrote:
The year-end sales report from a veterinary vaccine company states the following:

    A regulation significantly curbing the use of mink furs to manufacture garments was passed during the middle of this year. However, compared to last year, there was no change in the revenues from the sales of the vaccine Minkvac that is mandatory to be administered to all the minks that are used to manufacture garments.

Because of the above report, the managers of the vaccine company did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year.

Which of the following options, if true, indicates most strongly that the projection made by the managers for the next year mentioned in the passage would most likely not be met?


A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.


 


This question was provided by GMAT Club
for the GMAT Club World Cup Competition

Compete, Get Better, Win prizes and more

 



Thank you sayantanc2k for the question!!!


Manager's projection: Because of the above report, the managers of the vaccine company did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year.

A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.
INCORRECT. How much revenues will another vaccine bring is irrelevant to the argument. The projection talks solely of revenues from Minkvac.

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.
INCORRECT. Again how the Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned is not relevant to the argument. The projection talks solely of revenues from Minkvac.

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.
INCORRECT. This may one of the reason why revenues may be impacted, but effectiveness of the vaccine reduced from 90% to 80% will be the least concern for buyers if there is a regulation significantly curbing the use of mink furs to manufacture garments was passed during the middle of this year. Even if effectiveness stayed at 90%, the revenues for next year could well be impacted.

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.
CORRECT. If all the vaccines were already bought in the first quarter of the year, before the restriction was in effect, the projection of sales of the Minkvac vaccine for the following year put forward by managers will not be accurate. Many buyers who bought the vaccine in the first quarter of this year will opt out from buying the vaccines knowing the restriction is in place.

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.
INCORRECT. This is again irrelevant to the crux of the argument. In fact this statement slightly strengthen the argument by pointing that even though some high performing managers responsible for Minkvac sales left last year, the revenues from Minkvac this year were not affected. This shows that the old managers are not factors in increased sales, and thus next year the sales figure can very well see the same projection of sales.
Manager
Manager
Joined: 18 Feb 2021
Posts: 77
Own Kudos [?]: 69 [1]
Given Kudos: 13
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
[quote="Bunuel"]The year-end sales report from a veterinary vaccine company states the following:

    A regulation significantly curbing the use of mink furs to manufacture garments was passed during the middle of this year. However, compared to last year, there was no change in the revenues from the sales of the vaccine Minkvac that is mandatory to be administered to all the minks that are used to manufacture garments.

Because of the above report, the managers of the vaccine company did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year.

Which of the following options, if true, indicates most strongly that the projection made by the managers for the next year mentioned in the passage would most likely not be met?


A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.
This is incorrect. This will strengthen the manager's argument
B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.
This is out of scope as here we are concerned about the projected revenues from Minkvac
C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.
This is the incorrect. Because as the vaccination is mandatory even though the vaccine is 80% effective minkvac would still be used
D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.
This is the correct choice. As the regulation was passed middle of the year and the vaccines are sold in the 1st quarter thus though the sales were not down for the current year ,next year first quarter the sale will drop
E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.
-This option is out of scope
Intern
Intern
Joined: 21 Feb 2021
Posts: 30
Own Kudos [?]: 11 [0]
Given Kudos: 12
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year. Irrelevant

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned. Irrelevant

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be. This could reduce the sales and revenue associated

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter. Seasonal nature (quarterly) of the disease is irrelevant when comparing revenues from this year with revenues from last year

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected. Even though high performers left last year, his years revenue was comparable with last years revenue, hence no impact.

Answer choice C
Manager
Manager
Joined: 18 Feb 2022
Posts: 68
Own Kudos [?]: 64 [0]
Given Kudos: 39
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
We want to prove that the projections might be incorrect. For that, we might to find a reason for the reason behind meeting the projections this year, despite the ban on the use of mink to manufacture garments.

Option D: If the vaccinations are mostly done in the first quarter, then the ban getting implemented after 2 quarters wouldn't affect the numbers - hence the projections were met. but might not meet next year - Correct choice.
Quant Chat Moderator
Joined: 22 Dec 2016
Posts: 3093
Own Kudos [?]: 4121 [1]
Given Kudos: 1851
Location: India
Concentration: Strategy, Leadership
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.

We want to find a reason why the projections made by the managers would not be met. This options does not provide any evidence as such. Hence this is out of scope

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.

Out of scope as we are considered about Minkvac

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.

Doesn't help give strong evidence that 80% will not meet the requirement. This is incorrect

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarte.

Correct. This indicates that the vaccines were sold before the regulation. Hence the number of vaccines sold henceforth will not meet the number

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.

Incorrect. Does not affect the argument

IMO D
Director
Director
Joined: 05 Jan 2020
Status:Admitted to IIM Shillong (PGPEx 2023-24)
Affiliations: CFA Institute; ICAI; BCAS
Posts: 588
Own Kudos [?]: 554 [1]
Given Kudos: 694
Location: India
WE 2: EA to CFO (Consumer Products)
GPA: 3.78
WE:Corporate Finance (Commercial Banking)
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
The argument is concerned with revenues of Minkvac. A and B relates to company's other vaccine and is in no way related to revenues of Minkvac. Hence, A and B are wrong.

Even if the effectiveness of Minkvac is lower than previously thought, it is still required to be administered to minks that are used to manufacture garments. So, revenues of Minkvac may still be high next year. This is the opposite of what we want to prove that that the projection made by the managers for the next year mentioned in the passage would most likely [b]not be met[\b]. Hence, C is out.

If almost all Minkvac are sold in the first quarter, revenues from Minkvac in the current year are reflecting the sales made before the new unfavorable regulation became effective. As the new regulation is already effective at the current year end, this gives us reason to believe that the next year's projections made last year will not be achieved. Hence, D is our answer.

Resignation of some high-performing sales managers last year did not impact Minkvac sales in the current year. So, this factor does not have any bearing on next year's sales projections of Minkvac. Hence, E is wrong.

Answer is D for the above-mentioned reasons.
Manager
Manager
Joined: 14 Aug 2021
Posts: 64
Own Kudos [?]: 56 [1]
Given Kudos: 53
Location: India
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
1
Kudos
Conclusion: The managers did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year.

Evidence: no change in the revenues from the sales of the vaccine Minkvac that is mandatory to be administered to all the minks that are used to manufacture garments.

Any answer choice that will show that the revenue for the year was not dependent on the new regulation or the revenue collection happened before the ammendment of the regulation, then that answer will certainly confirm that the projection made by the managers for the next year mentioned in the passage would most likely not be met. Because the data was before the regulation and they would never know the consequences of the new regulation.
Hence answer choice is (D)
VP
VP
Joined: 03 Jul 2022
Posts: 1238
Own Kudos [?]: 799 [0]
Given Kudos: 21
GMAT 1: 680 Q49 V34
Send PM
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
The year-end sales report from a veterinary vaccine company states the following:

A regulation significantly curbing the use of mink furs to manufacture garments was passed during the middle of this year. However, compared to last year, there was no change in the revenues from the sales of the vaccine Minkvac that is mandatory to be administered to all the minks that are used to manufacture garments.


Because of the above report, the managers of the vaccine company did not reduce the projected revenues from Minkvac for the next year, a value that was estimated last year. Here.,a 'weakener' for the conclusion is required

Which of the following options, if true, indicates most strongly that the projection made by the managers for the next year mentioned in the passage would most likely not be met?

Projected Revenues will not be met. This can only happen when Minkvac vaccines are not sold in comparable quantities as those in last year.

A. A new vaccine, Catvac, developed by the company would bring in significant revenues next year.
It provides the reason owing to which there will be a reduction in sales of Minkvac,and thus the projected revenues will not be met..Correct as a 'weakener'

B. Development of the company’s another vaccine called Racoonvac was hindered because of safety concerns and will not be marketed next year as previously planned.
It furthers the cause of Minkvac sales..acts as a 'strengthener' for the conclusion

C. The latest clinical trial results for Minkvac have proven that the effectiveness of the vaccine is only 80% as compared to 90% previously thought to be.
Irrelevant..in fact slightly strengthens, since slightly reduced effectiveness will force the owners to buy greater quantities of the Minkvac vaccine

D. Minkvac is a vaccine against a seasonal disease that spreads in the second quarter of the year and hence almost all the vaccines are sold in the first quarter.
Out of scope..seasonal variation in sales is applicable for both years

E. Even though some high-performing sales managers responsible for Minkvac sales left the company last year, the revenues from Minkvac this year are not affected.
Sales personnel' trend can't be extrapolated for sales' comparison ..based on the reasoning presented in the stimulus..an irrelevant option

(A) is the correct answer
GMAT Club Bot
Re: GMAT Club World Cup 2022 (DAY 8): The year-end sales report from a vet [#permalink]
 1   2   
Moderators:
GMAT Club Verbal Expert
6923 posts
GMAT Club Verbal Expert
238 posts
CR Forum Moderator
832 posts

Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne